News Release

Early transcatheter valve recipient honored with Courageous Patient Award at TCT 2010

Grant and Award Announcement

Cardiovascular Research Foundation

WASHINGTON, DC – SEPTEMBER 24, 2010 – Lillian Feldshuh, of Scarsdale, NY, an early recipient of a transcatheter aortic valve in 2006, received the Courageous Patient Award yesterday at the Transcatheter Cardiovascular Therapeutics (TCT 2010) scientific symposium in Washington, DC. The procedure was a success and Feldshuh, who will turn 100 years in just 7 months, remains in good health.

In 2006, Lillian Feldshuh suffered from aortic stenosis, a severely life-threatening heart condition. Even though she had been told there were no options, the team at NewYork-Presbyterian Hospital/Columbia University Medical Center, led by Dr. Martin B. Leon, performed percutaneous aortic valve replacement on the then 95-year-old woman. On September 23rd, that team presented her with the award.

Mrs. Feldshuh was accompanied to Washington by her children, Broadway actress Tovah Feldshuh and playwright and physician David Feldshuh. She delivered her acceptance remarks to an audience of over 3,000 physicians.

"In June 2006, I was given the choice to die or take the chance to live. Naturally, I chose to take the chance to live. Maybe I'm a pioneer, I don't know. But I accept this award with gratitude and wonder. Who could have predicted in 1911 that in my hundredth year I would be receiving an award from the finest doctors in the world? I've had a blessed life. To reach this time and these years and be with you today, life is wonderful. I thank you from the bottom of my heart," Feldshuh said.

Still in an experimental phase, transcatheter valves may become a treatment option for people with a life threatening condition known as aortic stenosis, according to new data presented this week at TCT, and in an article in the New England Journal of Medicine.

###

About CRF and TCT

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from over 90 countries around the world to present and discuss the latest developments in the field.

For more information, visit www.crf.org.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.